Related Experiment Video
Updated: May 22, 2025

07:42
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
259
Sensing mycobacteria through unconventional pathways
The Journal of Clinical Investigation
|March 17, 2025
Summary
Mycobacterium tuberculosis infection requires new treatments. Researchers found that the cell wall lipid trehalose-6-monomycolate (TMM) acts as a T cell antigen, crucial for understanding tuberculosis immunity.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Tuberculosis (TB) affects a quarter of the global population, necessitating novel vaccines and therapies, especially against multidrug-resistant strains.
- Understanding the immune response to Mycobacterium tuberculosis is critical for developing effective interventions.
Purpose of the Study:
- To identify novel T cell antigens presented by CD1b molecules in Mycobacterium tuberculosis infection.
- To characterize the T cells that recognize these antigens and their role in active TB disease.
Main Methods:
- A multidisciplinary approach was employed to investigate the interaction between mycobacterial lipids and T cells.
- Analysis of T cell receptors and frequencies in individuals with active TB.
Main Results:
- Trehalose-6-monomycolate (TMM), a mycobacterial cell wall lipid, was identified as a T cell antigen presented by CD1b.
- T cells specific for CD1b-TMM complexes exhibited conserved T cell receptor features.
- Elevated frequencies of CD1b-TMM-specific T cells were observed in individuals with active TB disease.
Conclusions:
- TMM plays a dual role in stimulating both innate and adaptive immunity.
- These findings enhance the understanding of CD1-mediated lipid recognition by unconventional T cells in the context of TB.
- This research opens new avenues for TB vaccine and therapeutic development targeting TMM-CD1b interactions.

